/Companies

Compagos

Zurich, CH · 1 known investors

Find your way into Compagos

Sign up to see every warm intro you have to Compagos

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Compagos team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CompagOs develops Bon3OID, a biohardware platform that combines 3D bioprinted bone-like tissue constructs with hardware for controlled mechanical loading to produce functional readouts of bone remodeling. It serves preclinical drug development and translational diagnostics as a human-relevant in-vitro alternative to animal models for bone-focused research.

Investors · 1

Frequently asked questions

What does Compagos do?
CompagOs develops Bon3OID, a biohardware platform that combines 3D bioprinted bone-like tissue constructs with hardware for controlled mechanical loading to produce functional readouts of bone remodeling. It serves preclinical drug development and translational diagnostics as a human-relevant in-vitro alternative to animal models for bone-focused research.
Who are Compagos's investors?
Compagos's investors include Kickfund.
Where is Compagos headquartered?
Compagos is headquartered in Zurich, CH.